Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-31 07:05 am Purchase | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | HALPERN JOHN D | 550,894 9.99% | 98,611 (+21.80%) | View |
| 2024-01-19 10:31 am Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | Singer Nicholas Jason | 600,480 9.99% | 43,070 (+7.73%) | View |
| 2023-12-22 12:05 pm Unchanged | 13D | ETERNA THERAPEUTICS INC ERNA | Cherington Charles | 1,212,526 19.99% | 0 (Unchanged) | View |
| 2023-12-20 3:24 pm Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | IAF LLC | 576,964 9.99% | 576,964 (New Position) | View |
| 2023-09-08 06:07 am Unchanged | 13G | ETERNA THERAPEUTICS INC ERNA | Singer Nicholas Jason | 557,410 9.9% | 0 (Unchanged) | View |
| 2023-09-07 5:26 pm Purchase | 13D | ETERNA THERAPEUTICS INC ERNA | Cherington Charles | 1,212,526 19.99% | 645,000 (+113.65%) | View |
| 2023-08-28 4:57 pm Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | Purchase Capital LLC | 280,422 5% | 280,422 (New Position) | View |
| 2023-07-26 5:05 pm Purchase | 13D | ETERNA THERAPEUTICS INC ERNA | Singer Nicholas Jason | 557,410 9.99% | 557,410 (New Position) | View |
| 2023-07-20 7:52 pm Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | Freebird Partners LP | 1,053,487 19.99% | 355,976 (+51.04%) | View |
| 2023-04-04 5:14 pm Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | Freebird Partners LP | 697,511 12.6% | 424,928 (+155.89%) | View |
| 2023-03-06 4:07 pm Sale | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | DENNY GEORGE P III | 460,413 15.6% | -4,447,579 (-90.62%) | View |
| 2023-01-31 4:05 pm Purchase | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | HALPERN JOHN D | 452,283 8.8% | 1,117 (+0.25%) | View |
| 2022-12-20 4:30 pm Sale | 13D | BROOKLYN IMMUNO THERAPEUTICS L BTX | Singer Nicholas Jason | 393,766 7.67% | -1,701,234 (-81.20%) | View |
| 2022-12-14 4:30 pm Purchase | 13D | ETERNA THERAPEUTICS INC ERNA | Cherington Charles | 567,526 11.05% | 567,526 (New Position) | View |
| 2022-12-05 5:20 pm Sale | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | HALPERN JOHN D | 451,166 8.8% | -4,296,079 (-90.50%) | View |
| 2022-12-02 5:01 pm Purchase | 13G | ETERNA THERAPEUTICS INC ERNA | Freebird Partners LP | 272,583 5.3% | 272,583 (New Position) | View |
| 2022-03-16 4:30 pm Sale | 13D | BROOKLYN IMMUNO THERAPEUTICS L BTX | Cherington Charles | 5,913,365 11.4% | -399,932 (-6.33%) | View |
| 2022-02-16 5:15 pm Sale | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | Singer Nicholas Jason | 2,095,000 4% | -1,696,983 (-44.75%) | View |
| 2021-08-27 5:26 pm Purchase | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | Factor Bioscience Inc. | 4,670,980 9% | 4,670,980 (New Position) | View |
| 2021-05-26 10:05 am Sale | 13G | BROOKLYN IMMUNO THERAPEUTICS L BTX | Custard & Pitts Investment Co. LP | 1,839,521 4.43% | -250,000 (-11.96%) | View |